If you are wondering whether Baxter International's current share price reflects its underlying worth, this article is ...

The Deerfield-based medical device and pharmaceutical company is facing down a balance sheet loaded with debt and business ...

Shares of Baxter International Inc. slid 4.37% to $20.15 Monday, on what proved to be an all-around favorable trading session ...

What Happened? Shares of healthcare company Baxter International (NYSE:BAX) fell 4.5% in the afternoon session after Barclays ...

Versatile, scalable design allows a range of procedures to be performed in-stretcher, reducing the need for unnecessary ...

In December 2025, Baxter International Inc. completed the final settlement of its cash tender offers, retiring all of its ...

(Reuters) -Baxter International Inc said on Monday a private-equity group, which includes Warburg Pincus and Advent International, has agreed to buy its biopharma solutions unit for $4.25 billion.

Baxter International, a global healthcare products company with more than $15 billion in annual revenue, kicked off 2023 with the new year’s resolution of becoming streamlined and nimble. Five months ...

Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the J.P. Morgan 2026 Healthcare Conference on Monday, January 12, 2026. Andrew Hider, Baxter’s president and chief ...

Charleston, S.C.-based MUSC Health is collaborating with medtech company Baxter International to create efficiencies and alleviate administrative burden for nurses with technology. The multiyear ...

Learn more about whether AtriCure, Inc. or Baxter International Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.